Type 1 Diabetes News and Research

Latest Type 1 Diabetes News and Research

Experimental drug selectively destroys blood supply of fat tissue and decreases body fat

Obese rhesus monkeys lost on average 11 percent of their body weight after four weeks of treatment with an experimental drug that selectively destroys the blood supply of fat tissue, a research team led by scientists at The University of Texas MD Anderson Cancer Center reports in Science Translational Medicine.

10 Nov 2011

Electrochemical sensor device can measure blood sugar levels from tears

Scientists are reporting development and successful laboratory testing of an electrochemical sensor device that has the potential to measure blood sugar levels from tears instead of blood - an advance that could save the world's 350 million diabetes patients the discomfort of pricking their fingers for droplets of blood used in traditional blood sugar tests.

10 Nov 2011

Medtronic initiates enrollment in Enlite Sensor study for diabetes

Medtronic, Inc. today announced a new United States investigational device exemption study to evaluate the accuracy of six-day use in adults with diabetes of its Enlite Sensor, the company's latest innovation in continuous glucose monitoring (CGM) technology for people with diabetes.

From Medtronic 10 Nov 2011

Conventional definition of obesity needs to be lowered in migrant South Asians

A major study calling for levels of obesity among South Asians to be recalculated has been published by researchers from the University of Leicester.

9 Nov 2011

Study examines psychological factors related to diabetes management

Genetics play a critical role in developing diabetes. So do eating properly, exercising and not smoking. According to a new study by an Ithaca College psychology professor and her two colleagues, people with diabetes who see themselves as responsible for their disease onset blame themselves for making poor lifestyle choices and are significantly less likely to monitor their glucose levels, properly inject themselves and make lifestyle choices that would benefit their condition.

9 Nov 2011

Insulin resistance associated with cortical atrophy and brain dysfunction

Many complications of diabetes, including kidney disease, foot problems and vision problems are generally well recognized. But the disease's impact on the brain is often overlooked.

9 Nov 2011

Amylin and Lilly terminate exenatide alliance, resolve litigation

Amylin Pharmaceuticals, Inc. and Eli Lilly and Company today announced an agreement to terminate their alliance for exenatide and resolve the outstanding litigation between the companies.

9 Nov 2011

Prognomix, Servier enter R&D agreement to identify novel type 2 diabetes targets

Les Laboratoires Servier, France (Servier) and Prognomix Inc., Canada (Prognomix) announced today that they have entered into a research and development agreement aimed at identifying novel targets as part of programs meant to develop innovative type 2 diabetes and metabolic disease treatment.

9 Nov 2011

Omeros third quarter net loss decreases to $6.5 million

Omeros Corporation, a clinical-stage biopharmaceutical company committed to discovering, developing and commercializing products targeting inflammation, coagulopathies and disorders of the central nervous system, today announced its financial results for the third quarter of 2011.

9 Nov 2011

Scripps scientist receives Novo Nordisk grant for research into diabetes

Andrew Butler, an associate professor in The Scripps Research Institute's Department of Metabolism and Aging, has been awarded one million dollars in funding over the next two years to further his research into a novel protein with the potential to improve the understanding and future treatment of diabetes.

9 Nov 2011

Connexin 36 protects mouse pancreatic beta-cells against immune molecules

Type 1 diabetes is a lifelong disease characterized by high levels of sugar (glucose) in the blood. It is caused by the patient's immune system attacking and destroying the cells in their pancreas that produce the hormone insulin, which regulates blood glucose levels. Surprisingly, little is known about the mechanisms regulating the sensitivity and resistance of these cells, which are known as beta-cells, to immune system attack.

7 Nov 2011

Mediterranean Diet beneficial even without weight loss

The benefits of the Mediterranean Diet go beyond weight loss, even when weight loss isn't achieved. Researchers from St. Vincent's Hospital, Melbourne, studied 12 patients without diabetes who had nonalcoholic fatty liver disease (NAFLD), and the results of their study demonstrated that liver health was improved even without weight loss.

7 Nov 2011

New study questions effectiveness of current exercise referral schemes

Research commissioned by the NIHR Health Technology Assessment programme and carried out by research teams from the Peninsula College of Medicine and Dentistry (PCMD) and the Universities of Exeter (Sport and Health Sciences) and Brunel (Health Economics Research Group), has called into question the effectiveness of exercise referral schemes as they are delivered at present.

7 Nov 2011

More than half of all Americans will have diabetes by 2020

Half of all American adults are destined to develop diabetes or pre-diabetes by 2020 if they don't make dramatic lifestyle changes, according to a dire new prediction from the Centers for Disease Control and Prevention.

5 Nov 2011

Cabot's 5-Day Menu Planner seeks to refocus eating habits to balance nutrition

November is American Diabetes Month, and the American Diabetes Association has released some startling facts on just how prevalent the disease has become in the United States.

5 Nov 2011

Sweet'N Low joins with Dominique Dawes to educate consumers about risk of type 2 diabetes

In honor of Diabetes Awareness Month, Sweet'N Low, America's iconic zero-calorie 'pink' sweetener, has joined forces with gold medalist, Dominique Dawes, to educate consumers about the growing epidemic. According to the American Diabetes Association, nearly 26 million American's have diabetes, 7 million of whom are currently undiagnosed.

5 Nov 2011

Exercise, vegetarian diet reduce risk of diabetes in African Americans

New research shows that following a vegetarian diet and exercising at least three times a week significantly reduced the risk of diabetes in African Americans, who are twice as likely to be diagnosed with diabetes when compared to non-Hispanic whites.

4 Nov 2011

UofL intervention program for caregivers of people with IDD

People with intellectual and developmental disabilities living in family or group homes are less likely to receive routine dental care than those living in institutions, according to University of Louisville School of Dentistry associate professor Catherine Binkley, D.D.S., Ph.D.

4 Nov 2011

NEJM publishes 'The 2010 Dietary Guidelines -- The Best Recipe for Health?'

USDA's interest protects that of Industry -- not the American public, conclude leading researchers Water C. Willett, MD, PhD, and David S. Ludwig, MD, PhD in their article, "The 2010 Dietary Guidelines -- The Best Recipe for Health?" published in the prestigious peer-reviewed The New England Journal of Medicine.

4 Nov 2011

FDA accepts VIVUS' Qnexa NDA for filing and review

VIVUS, Inc. today announced that the U.S. Food and Drug Administration (FDA) has accepted for filing and review the New Drug Application (NDA) for Qnexa to treat obesity. The company resubmitted the NDA on October 17, 2011.

4 Nov 2011